Cancer research is inherently complex due to the heterogeneity of the disease. Each type of cancer can have multiple subtypes, each with its own genetic and molecular profile. This heterogeneity makes it challenging to develop universal treatments. Researchers must also consider the role of the tumor microenvironment, the immune system, and other factors that can influence cancer growth and response to treatment.
